In-hospital outcomes associated with fibrinolytic and thienopyridine use in patients with st-segment elevation acute myocardial infarction. The global registry of acute coronary events;Evolución hospitalaria asociada al empleo de fibrinolíticos y tienopiridinas en pacientes con infarto agudo de miocardio y elevación del segmento ST. The Global Registry of Acute Coronary Events

Revista Espanola de Cardiologia

Volumn 62, Issue 5, 2009, Pages 501-509

  López Sendón, José ^a   Dabbous, Omar H ^b   López De Sá, Esteban ^a   Stiles, Martin ^c   Gore, Joel M ^b   Brieger, David ^d   Van De Werf, Frans ^e   Budaj, Andrzej ^f   Gurfinkel, Enrique P ^g   Fox, Keith A A ^h  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d ANZAC Research Institute   (Australia)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f Hospital Grochowski   (Poland)

^g HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^h ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Acute coronary syndromes; Anticoagulantes; Anticoagulants; Fibrinol ticos; Fibrinolytics; Infarto agudo de miocardio con elevaci n de ST; S ndromes coronarios agudos; ST elevation myocardial infarction; Thienopyridines; Tienopiridinas

Indexed keywords

ALTEPLASE; CLOPIDOGREL; FIBRINOLYTIC AGENT; STREPTOKINASE; TENECTEPLASE; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; PYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLEEDING; FEMALE; FIBRINOLYTIC THERAPY; HEART CATHETERIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; REGISTER; RISK FACTOR; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; ACUTE DISEASE; BIOASSAY; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; HEART INFARCTION; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CORONARY DISEASE; ELECTROCARDIOGRAPHY; ENDPOINT DETERMINATION; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; PYRIDINES; REGISTRIES;

EID: 68049117142     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(09)71030-9     Document Type: Article

References (31)

1. E.M. Antman, D.T. Anbe, P.W. Armstrong, E.R. Bates, L.A. Green, and M. Hand ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 210 247
2. J.L. Anderson, C.D. Adams, E.M. Antman, C. Bridges, R. Califf, and D. Casey ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction Am J Cardiol 50 2007 652 726
3. F. Van de Werf, D. Ardissino, A. Betriu, D.V. Cokkinos, E. Falk, and K.A. Fox Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 24 2003 28 66
4. J.P. Bassand, C.W. Hamm, D. Ardissino, E. Boersma, A. Budja, and F. Fernandezz Aviles Guidelines for the diagnosis and treatment of non ST-elevation acute coronary syndromes. The Task Force on the management of acute coronary syndromes of the European Society of Cardiology Eur Heart J 28 2007 1598 1660
5. R.C. Becker, M. Burns, N. Every, C. Maynard, P. Frederick, and F.A. Spencer Early clinical outcomes and routine management of patients with non-ST-segment elevation myocardial infarction: a nationwide perspective Arch Intern Med 161 2001 601 607
6. D. Hasdai, S. Behar, L. Wallentin, N. Danchin, A.K. Gitt, and E. Boersma A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS) Eur Heart J 23 2002 1190 1201
7. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
8. S.R. Mehta, S. Yusuf, R.J. Peters, M.E. Bertrand, B.S. Lewis, and M.K. Natarajan Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCICURE study Lancet 358 2001 527 533
9. M.S. Sabatine, C.P. Cannon, C.M. Gibson, J.L. López-Sendón, G. Montalescot, and P. Theroux Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 2005 1179 1189
10. Z.M. Chen, L.X. Jiang, Y.P. Chen, J.X. Xie, H.C. Pan, and R. Peto Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1607 1621
11. The GRACE Investigators Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes Am Heart J 141 2001 190 199
12. P.G. Steg, R.J. Goldberg, J.M. Gore, K.A. Fox, K.A. Eagle, and M.D. Flather Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE) Am J Cardiol 90 2002 358 363
13. K.A. Eagle, S.G. Goodman, A. Avezum, A. Budaj, C.M. Sullivan, and J. López-Sendón Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE) Lancet 359 2002 373 377
14. M. Moscucci, K.A. Fox, C.P. Cannon, W. Klein, J. López- Sendón, and G. Montalescot Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1815 1823 (Pubitemid 37280247)
15. C.B. Granger, R.J. Goldberg, O. Dabbous, K.S. Pieper, K.A. Eagle, and C.P. Cannon Predictors of hospital mortality in the Global Registry of Acute Coronary Events Arch Intern Med 163 2003 2345 2353
16. L. Mandelzweig, A. Battler, V. Boyko, H. Bueno, N. Danchin, G. Filippatos On behalf of the Euro Heart Survey Investigators The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004 Eur Heart J 27 2006 2285 2293
17. S.R. Steinhubl, P.B. Berger, J.T. Mann 3rd, E.T. Fry, A. DeLago, and C. Wilmer Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420
18. A.W. Chan, D.J. Moliterno, P.B. Berger, G.W. Stone, P.M. DiBattiste, and S.L. Yakubov Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET) J Am Coll Cardiol 42 2003 1188 1195
19. C. Mueller, H. Roskamm, F.J. Neumann, P. Hunziker, S. Marsch, and A. Perruchoud Randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents J Am Coll Cardiol 41 2003 969 973 (Pubitemid 36315539)
20. M.S. Sabatine, K.P. Cannon, C.M. Gibson, J.L. López-Sendón, G. Montalescot, P. Theroux The Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics. The PCI-CLARITY Study JAMA 294 2005 1224 1232
21. K.A. Fox, S.R. Mehta, R. Peters, F. Zhao, N. Lakkis, and B.J. Gersh Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial Circulation 110 2004 1202 1208
22. A. Kastrati, J. Mehilli, H. Schuhlen, J. Dirschinger, F. Dotzer, and J.M. Ten Berg A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel N Engl J Med 350 2004 232 238
23. Wolfram RM, MD, Torguson RL, Hassani SE, Xue Z, Gevorkian N, Pichard AD, et al. Clopidogrel loading dose (300 versus 600 mg) strategies for patients with stable angina pectoris subjected to percutaneous coronary intervention. Am J Cardiol. 2006;97:984-9.
24. P. Patti, G. Colonna, V. Pasceri, L. Lassandro, Montinaro., and G. Di Sciascio Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention. Results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) Study Circulation 111 2005 2099 2106
25. L. Bonello, L. Camoin-Jau, S. Arques, C. Boyer, D. Panagides, and O. Wittenberg Adjusted Clopidogrel Loading Doses According to Vasodilator- Stimulated Phosphoprotein Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel Resistance. A Multicenter Randomized Prospective Study J Am Coll Cardiol 51 2008 1404 1411
26. D.E. Cutlip, M.B. Leon, K.K. Ho, P.C. Gordon, A. Giambartolomei, and D.J. Diver Acute and nine-month clinical outcomes after "suboptimal" coronary stenting: results from the STent Anti-thrombotic Regimen Study (STARS) registry J Am Coll Cardiol 34 1999 698 706
27. H. Schuhlen, A. Kastrati, J. Pache, J. Dirschinger, and A. Schomig Sustained benefit over four years from an initial combined antiplatelet regimen after coronary stent placement in the ISAR trial. Intracoronary Stenting and Antithrombotic Regimen Am J Cardiol 87 2001 397 400
28. M.E. Bertrand, V. Legrand, J. Boland, E. Fleck, J. Bonnier, and H. Emmanuelson Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The Full anticoagulation versus aspirin and ticlopidine (FANTASTIC) study Circulation 98 1998 1597 1603
29. P. Urban, C. Macaya, H.J. Rupprecht, F. Kiemeneij, A. Emanuelsson, and A. Fontanelli Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients : The Multicenter Aspirin and Ticlopidine Trial after Intracoronary Stenting (MATTIS) Circulation 98 1998 2126 2132
30. P.B. Berger, and S. Steinhubl Clinical implications of percutaneous coronary intervention-clopidogrel in unstable angina to prevent recurrent events (PCI-CURE) study: a US perspective Circulation 106 2002 2284 2287
31. A. Laupacis, and M. Mamdani Observational studies of treatment effectiveness: some cautions Ann Intern Med 140 2004 923 924